» Articles » PMID: 39624213

Association Between Lactate/albumin Ratio and 28-day Mortality in ICU Critical Patients with Coronary Heart Disease: a Retrospective Analysis of the MIMIC-IV Database

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The serum lactate/albumin ratio (LAR) is commonly employed for monitoring and evaluating the prognosis of critically ill patients. Both elevated lactate levels and decreased albumin levels may reflect the body's stress response and inflammatory reaction. Coronary heart disease (CHD), with common complications including myocardial infarction, arrhythmia, heart failure, is one of the leading causes of global death. Therefore, it is crucial to explore biomarkers that can predict the prognosis and mortality of CHD patients.

Methods: This is a retrospective study in which the data is from the MIMIC-IV database. Our study assessed the association between LAR value and mortality within 28 days of admission in a total of 1,902 CHD patients from the Beth Israel Deaconess Medical Center.

Results: The results demonstrated a significant increase in 28-day mortality among individuals with higher LAR values. Multivariate analysis by Cox proportional hazard model revealed an incremental rise in mortality across each quartile with the increase of LAR value. Furthermore, restricted cubic spline (RCS) Cox regression analysis further revealed that higher LAR values were associated with increased 28-day mortality in the CHD patients. And subgroup analysis confirmed that the LAR level could serve as an independent predictor of 28-day mortality with CHD patients.

Conclusions: Our study demonstrated that the LAR value can be an important risk predictor of 28-day mortality in patients with CHD, and a higher LAR associate with increased mortality rate.

Citing Articles

Association between lactate-to-albumin ratio and all-cause mortality in critically ill cirrhotic patients with sepsis: a retrospective analysis of the MIMIC-IV database.

Ma Y, Du L, Bai L, Tang H BMC Gastroenterol. 2025; 25(1):112.

PMID: 39994557 PMC: 11853895. DOI: 10.1186/s12876-025-03686-5.

References
1.
Chen Y, Lai W, Yang K, Wu B, Xie D, Peng C . Association between lactate/albumin ratio and prognosis in patients with acute myocardial infarction. Eur J Clin Invest. 2023; 54(1):e14094. DOI: 10.1111/eci.14094. View

2.
Haschemi J, Muller C, Haurand J, Oehler D, Spieker M, Polzin A . Lactate to Albumin Ratio for Predicting Clinical Outcomes after In-Hospital Cardiac Arrest. J Clin Med. 2023; 12(12). PMC: 10298956. DOI: 10.3390/jcm12124136. View

3.
Wu Y, Ma W, Liu W, Zhang S . Lactate: a pearl dropped in the ocean-an overlooked signal molecule in physiology and pathology. Cell Biol Int. 2022; 47(2):295-307. DOI: 10.1002/cbin.11975. View

4.
Park J, Chung K, Song J, Kim S, Kim E, Jung J . The C-Reactive Protein/Albumin Ratio as a Predictor of Mortality in Critically Ill Patients. J Clin Med. 2018; 7(10). PMC: 6210319. DOI: 10.3390/jcm7100333. View

5.
Malakar A, Choudhury D, Halder B, Paul P, Uddin A, Chakraborty S . A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol. 2019; 234(10):16812-16823. DOI: 10.1002/jcp.28350. View